HMGB1 and autoimmune polyendocrinopathy: The results showed that the APS patients, either PAPS or SAPS, showed significantly increased serum levels of HMGB1, as compared to healthy subjects (Figure 3A), as revealed by densitometric analysis (p < 0.0001).